Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'methamphetamine synth' OR with Authors including 'methamphetamine synth' OR with Abstract including 'methamphetamine synth' OR with Keywords including 'methamphetamine synth'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Fuller RW, Hines CW, Mill... Lowering of Brain Serotonin Levels by Chloramphetamines Biochem Pharmacol 1965
Barfknecht CF, Nichols DE Potential psychotomimetics, Bromomethoxyamphetamines J Med Chem 1971
Barfknecht CF, Nichols DE Potential psychotomimetics. Bromomethoxyamphetamines J Med Chem 1971
Sreenivasan VR Problems in Identification of Methylenediony and Methoxy Amphetamines Journal of Criminal ... 1972
Caldwell J, Sever PS The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... Clin.Pharmacol.Ther. 1974
Murdock JE, Shulgin AT A novel illicit amphetamine laboratory Microgram 1978
Schmidt CJ, Sonsalla PK, ... Methamphetamine-induced depression of monoamine synthesis in the rat: ... J Neurochem 1985
Seymour RB, Wesson DR, Sm... Editor's Introduction J Psychoactive Drugs 1986
Dowling GP, McDonough ET ... 'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... JAMA 1987
Stone DM, Merchant KM, Ha... Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... Neuropharmacology 1987
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Scallet AC, Lipe GW, Ali ... Neuropathological evaluation by combined immunohistochemistry and dege... Neurotoxicology 1988
Schmidt CJ, Taylor VL Direct central effects of acute methylenedioxymethamphetamine on serot... Eur J Pharmacol 1988
Cozzi NV, Sievert MK, Shu... Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-o... Soc. Neurosci. Abs 1988
Fitzgerald RL, Blanke RV,... Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... J Chromatogr 1989
Johnson M, Stone DM, Bush... Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... Eur J Pharmacol 1989
Schmidt CJ Acute and long-term neurochemical effects of methylenedioxymethampheta... NIDA Res Monogr 1989
Stone DM, Hanson GR, Gibb... In vitro reactivation of rat cortical tryptophan hydroxylase following... J Neurochem 1989
Gibb JW, Stone DM, Johnso... Role of dopamine in the neurotoxicity induced by amphetamines and rela... NIDA Res Monogr 1989
Callaway CW, Wing LL, Gey... Serotonin release contributes to the locomotor stimulant effects of 3,... J Pharmacol Exp Ther 1990
Nash JF, Meltzer HY, Gude... Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalan... J Neurochem 1990
Schmidt CJ, Abbate GM, Bl... Selective 5-hydroxytryptamine2 receptor antagonists protect against th... J Pharmacol Exp Ther 1990
Schmidt CJ, Black CK, Tay... Antagonism of the neurotoxicity due to a single administration of meth... Eur J Pharmacol 1990
Schmidt CJ, Kehne JH Neurotoxicity of MDMA: neurochemical effects Ann N Y Acad Sci 1990
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Lim HK, Foltz RL In vivo formation of aromatic hydroxylated metabolites of 3,4-(methyle... Biol Mass Spectrom 1991
Pan HS, Wang RY The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... Brain Res 1991
Schechter MD Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... Gen Pharmacol 1991
Schmidt CJ, Taylor VL, Ab... 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... J Pharmacol Exp Ther 1991
Hanson GR, Bunker CF, Joh... Response of monoaminergic and neuropeptide systems to 4-methylaminorex... Eur J Pharmacol 1992
Preston A Pointing out the Risk Nursing Times 1992
Schmidt CJ, Black CK, Tay... The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... Eur J Pharmacol 1992
Schmidt CJ, Fadayel GM, S... 5-HT2 receptors exert a state-dependent regulation of dopaminergic fun... Eur J Pharmacol 1992
Singarajah C, Lavies NG An overdose of ecstasy: A role for dantrolene Anaesthesia 1992
Zhao ZY, Castagnoli N Jr,... Synthesis and neurotoxicological evaluation of putative metabolites of... Chem Res Toxicol 1992
Bohn M, Bohn G, Blaschke ... Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... Int J Legal Med 1993
Huang X, Nichols DE 5-HT2 receptor-mediated potentiation of dopamine synthesis and central... Eur J Pharmacol 1993
Maxwell DL, Polkey MI, He... Hyponatraemia and catatonic stupor after taking 'ecstasy' BMJ 1993
Rothwell PM, Grant R Cerebral venous sinus thrombosis induced by 'ecstasy' J Neurol Neurosurg P... 1993
Shiue CY, Shiue GG, Rysav... Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, dist... Nucl Med Biol 1993
McDowell DM, Kleber HD MDMA: Its history and pharmacology Psychiatric Annals 1994
Marona-Lewicka D, Nichols... Behavioral effects of the highly selective serotonin releasing agent 5... Eur J Pharmacol 1994
McCoy EP, Renfrew C, John... Malignant hyperpyrexia in an MDMA ('Ecstasy') abuser Ulster Med J 1994
Schmidt CJ, Sullivan CK, ... Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increa... J Neurochem 1994
Steele TD, McCann UD, Ric... 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... Addiction 1994
White SR, Duffy P, Kaliva... Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firi... Neuroscience 1994
Bryden AA, Rothwell PJ, O... Urinary retention with misuse of 'ecstasy' BMJ 1995
Green AR, Cross AJ, Goodw... Review of the pharmacology and clinical pharmacology of 3,4-methylened... Psychopharmacology (... 1995
Poblete JC, Azmitia EC Activation of glycogen phosphorylase by serotonin and 3,4-methylenedio... Brain Res 1995
Miller RT, Serrine SL, Mo... Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... Chem Res Toxicol 1995
Miller RT, Lau SS, Monks ... Effects of intracerebroventricular administration of 5-(glutathion-S-y... Chem Res Toxicol 1996
Gudelsky GA, Nash JF Carrier-mediated release of serotonin by 3,4-methylenedioxymethampheta... J Neurochem 1996
Lin LY, Fujimoto M, Diste... Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymetha... J Pharmacol Exp Ther 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Gifford AN, Minabe Y, Too... Examination of the action of 3,4-methylenedioxymethamphetamine on rat ... Synapse 1996
Geyer MA Serotonergic functions in arousal and motor activity Behav Brain Res 1996
Obradovic T, Imel KM, Whi... Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... Neuroscience 1996
Taraska T, Finnegan KT Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-met... J Pharmacol Exp Ther 1997
Brauer RB, Heidecke CD, N... Liver transplantation for the treatment of fulminant hepatic failure i... Transpl Int 1997
Zheng Y, Laverty R Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (... Brain Res 1998
Muck-Seler D, Takahashi S... The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT syn... Brain Res 1998
Sprague JE, Everman SL, N... An integrated hypothesis for the serotonergic axonal loss induced by 3... Neurotoxicology 1998
Sabol KE, Seiden LS Reserpine attenuates D-amphetamine and MDMA-induced transmitter releas... Brain Res 1998
Cozzi NV, Shulgin AT, Ruo... Methcathinone (MCAT) and 2-methylamino-1-(3,4-methylenedioxyphenyl)pro... Amer. Chem. Soc. Div... 1998
Stein DJ, Rink J Effects of 'Ecstasy' blocked by serotonin reuptake inhibitors J Clin Psychiatry 1999
Westwood SC, Hanson GR Effects of stimulants of abuse on extrapyramidal and limbic neuropepti... J Pharmacol Exp Ther 1999
Nishisawa S, Mzengeza S, ... Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin ... Neurochem Int 1999
Navarro JF, Maldonado E Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in ago... Prog Neuropsychophar... 1999
Schirren CA, Berghaus TM,... Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... Ann Intern Med 1999
Erdtmann-Vourliotis M, Ma... Acute injection of drugs with low addictive potential (delta(9)-tetrah... Brain Res Mol Brain ... 1999
McFee RB, Mofenson HC, Ca... Dextromethorphan: Another 'Ecstasy'? Arch Fam Med 2000
de la Torre R, Farré M, O... Non-linear pharmacokinetics of MDMA (`ecstasy') in humans Br J Clin Pharmacol 2000
de la Torre R, Farre M, O... Non-linear pharmacokinetics of MDMA ('ecstasy') in humans Br J Clin Pharmacol 2000
Aalberg L, DeRuiter J, No... Chromatographic and Mass Spectral Methods of Identification for the Si... J Chromatogr Sci 2000
Christophersen AS Amphetamine designer drugs - an overview and epidemiology Toxicol Lett 2000
Kuhn DM, Geddes TJ Molecular footprints of neurotoxic amphetamine action [In Process Cita... Ann N Y Acad Sci 2000
Kavanagh P, Dunne J, Feel... Phenylalkylamine abuse among opiate addicts attending a methadone trea... Addict Biol 2001
Maldonado E, Navarro JF Mdma (‘ecstasy’) exhibits an anxiogenic-like activity in social encoun... Pharmacological Rese... 2001
Colado MI, Camarero J, Me... A study of the mechanisms involved in the neurotoxic action of 3,4- me... Br J Pharmacol 2001
Stuerenburg HJ, Petersen ... Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and... Neuroendocrinol Lett 2002
O'Shea E, Easton N, Fry J... Protection against 3,4-methylenedioxymethamphetamine-induced neurodege... J Neurochem 2002
Boot BP, Mechan AO, McCan... MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentratio... Eur J Pharmacol 2002
Lebsanft HB, Mayerhofer A... Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... J Neural Transm 2003
Dumasia MC Identification of some N-hydroxylated metabolites of +/--3,4-methylene... Xenobiotica 2003
Halpern JH Hallucinogens: an update Curr Psychiatry Rep 2003
Easton N, Fry J, O'Shea E... Synthesis, in vitro formation, and behavioural effects of glutathione ... Brain Res 2003
Dafters RI, Biello SM The effect of 3,4-methylenedioxymethamphetamine ('Ecstasy') on seroton... Neurosci Lett 2003
Moyano S, Frechilla D, De... NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... Psychopharmacology (... 2004
Garcia-Osta A, Del Rio J,... Increased CRE-binding activity and tryptophan hydroxylase mRNA express... Brain Res Mol Brain ... 2004
Segura M, Farre M, Pichin... Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetami... Clin Pharmacokinet 2005
Casteele SR, Bouche MP, V... LC-MS/MS in the elucidation of an isomer of the recreational drug meth... J Sep Sci 2005
Burchett SA, Hicks TP The mysterious trace amines: protean neuromodulators of synaptic trans... Prog Neurobiol 2006
Freudenmann RW, Oxler F, ... The origin of MDMA (ecstasy) revisited: the true story reconstructed f... Addiction 2006
Freudenmann RW, Oxler F, ... The origin of MDMA (ecstasy) revisited: the true story reconstructed f... Addiction 2006
Capela JP, Macedo C, Bran... Neurotoxicity mechanisms of thioether ecstasy metabolites Neuroscience 2007
Silins E, Copeland J, Dil... Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use o... Aust N Z J Psychiatr... 2007
Rogers G, Elston J, Garsi... The harmful health effects of recreational ecstasy: a systematic revie... Health Technol Asses... 2009
Ambrose JB, Bennett HD, L... Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingest... Neurologist 2010
Winstock AR, Mitcheson LR... Mephedrone, new kid for the chop? Addiction 2010

Page 1 of 2   /   129 Entries Returned
2 next